Clinical research for ‘hydrogen inhalation therapy’ in more than 10 hospitals across Japan has proved it can help patients who have suffered from cardiac arrests.
The research, initially conducted on laboratory rats in 2012, proved that damage to brain functions and heart muscle tissues was reduced by inhaling hydrogen (H2) after cardiopulmonary resuscitation.
The research accelerated from February this year, and patients who had been resuscitated after cardiopulmonary arrest were given a mixture of 98% O2 and 2% H2 to inhale for up to 18 hours. The research, which is based on a random patient selection process, will continue to be conducted for a further two years with a total of 360 individual cases examined.
... to continue reading you must be subscribed